IRADIMED CORPORATION to Hold 2020 First Quarter Financial Results Conference Call on April 30th
April 16, 2020 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 16, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 first quarter financial results before the...
IRADIMED CORPORATION Withdraws 2020 Financial Guidance Due to Uncertainties from the Effects of COVID-19
April 07, 2020 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 07, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced that it expects to report first quarter 2020 revenue of $8.6 million to $8.7 million and is...
IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development
March 12, 2020 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., March 12, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of Research and Development, effective March...
IRADIMED CORPORATION to Present at the 32nd Annual Roth Conference
March 06, 2020 09:50 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., March 06, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that Leslie McDonnell, President and Chief Executive Officer, will present at the 32nd...
IRADIMED CORPORATION Announces Retirement of Francis Casey and the Appointment of Steven Kachelmeyer as Vice President of Regulatory Affairs and Quality Assurance
February 26, 2020 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 26, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Francis Casey, Vice President of Regulatory Affairs and Quality Assurance,...
IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results
February 06, 2020 07:00 ET
|
iRadimed Corporation
Reports fourth quarter 2019 revenue of $10.9 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.30Renewed CE Mark for patient vital signs monitor and shipped associated backlog during...
IRADIMED CORPORATION to Hold 2019 Fourth Quarter Financial Results Conference Call on February 6th
January 22, 2020 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 22, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 fourth quarter financial results before the...
IRADIMED CORPORATION Announces Retirement of Brent Johnson and the Appointment of MaryBeth Smith as Vice President of Worldwide Sales
January 07, 2020 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 07, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Brent Johnson, Executive Vice President of Worldwide Sales and Marketing,...
IRADIMED CORPORATION Completes CE Mark Renewal Process For Its MRI Compatible Patient Vital Signs Monitoring System
December 12, 2019 08:55 ET
|
iRadimed Corporation
Immediately resumes shipments of patient vital signs monitoring systems into all markets requiring CE Mark WINTER SPRINGS, Fla., Dec. 12, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:...
IRADIMED CORPORATION Announces Third Quarter 2019 Financial Results
October 30, 2019 07:00 ET
|
iRadimed Corporation
Reports third quarter 2019 revenue of $10.0 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Updates full-year financial guidance WINTER SPRINGS, Fla., Oct. 30, 2019 (GLOBE...